March 7th 2021, 5:00am
Vamshi Rao, MD, attending physician of Neurology at Ann and Robert H. Lurie Children’s Hospital of Chicago discusses how new treatments will influence future care guidelines for spinal muscular atrophy (SMA).
March 3rd 2021, 8:58pm
Direct inpatient and outpatient costs are significantly higher for patients with untreated spinal muscular atrophy (SMA) compared with matched controls.
February 28th 2021, 12:45pm
Vamshi Rao, MD, attending physician of Neurology at Ann and Robert H. Lurie Children’s Hospital of Chicago, discusses the future of combination therapies in the spinal muscular atrophy (SMA) space.
February 26th 2021, 1:52pm
The results also showed that the infants achieved certain milestones in motor development, pulmonary function, and survival.
February 14th 2021, 3:45pm
Vamshi Rao, MD, attending physician of Neurology at Ann and Robert H. Lurie Children’s Hospital of Chicago, discusses the safety and efficacy of spinal muscular atrophy (SMA) treatments.
February 14th 2021, 12:00am
Speech impairment was primarily linked to motor impairment, according to a study examining the development trajectory of children with spinal muscular atrophy.
February 7th 2021, 2:30pm
Vamshi Rao, MD, attending physician of Neurology at Ann and Robert H. Lurie Children’s Hospital of Chicago discusses how the pandemic has impacted access to spinal muscular atrophy (SMA) treatments.
January 31st 2021, 12:00pm
Vamshi Rao, MD, attending physician of Neurology at Ann and Robert H. Lurie Children’s Hospital of Chicago, discusses how disease modifying therapies have improved spinal muscular atrophy (SMA) prognosis.
January 27th 2021, 5:30pm
While these therapies continue to revolutionize the treatment landscape of SMA, treatments are not without shortcomings or challenges.
January 24th 2021, 6:00pm
Documented issues include lipid metabolic abnormalities, glucose metabolic abnormalities, and altered vitamin levels.
